NCT03035513

Brief Summary

Continuous Spikes and Waves during Sleep (CSWS) is a rare paediatric epileptic encephalopathy. Even if the correlation between the severity of the epilepsy and the cognitive consequences is well established, the mechanisms involved in epileptic cognitive degradation are complex and poorly understood. In CSWS, there are many arguments for the implication of cortical and subcortical cerebral structures. Among them the thalamus seems to play a crucial role. In fact it is strongly implicated in the sleep and this function is determining for learning. Moreover, it is part of the propagation pathway of generalized forms of epilepsy like absences in animal studies. Unfortunately there is no animal model for CSWS to confirm this theory. In human studies, few cases are caused by thalamic injuries but most of the time conventional MRI is normal. Despite few literature on CSWS, some studies reported abnormal functional connectivity especially in the thalamus. The investigators hypothesize that the first utilisation of diffusion tensor imaging (DTI) and tractography will be useful in CSWS to confirm the implication of a cortico-thalamo-cortical network showing an abnormal structural connectivity. The investigators will try to determinate if a particular thalamic nucleus is concerned and demonstrate a link between the disease severity (duration and cognitive consequences) and the importance of structural abnormalities. Using resting state functional MRI (fMRI), the investigators will also try to investigate the default mode network. Its implication was also suggested in the literature.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

January 13, 2017

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 30, 2017

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2020

Completed
Last Updated

January 30, 2017

Status Verified

January 1, 2017

Enrollment Period

3.1 years

First QC Date

January 13, 2017

Last Update Submit

January 27, 2017

Conditions

Keywords

Continuous spikesEpilepsyNervous system diseaseNeuronal plasticityDiffusion MRIFunctional MRIwaves during slow sleep (CSWS)

Outcome Measures

Primary Outcomes (1)

  • Structural connectivity of the thalamo-cortical network

    Structural connectivity of the thalamo-cortical network will be assessed using DTI fractional anisotropy. The data of CSWS patients will be statistically compared to healthy volunteers

    at day 1

Secondary Outcomes (1)

  • Some comparisons with electrophysiological and neuropsychological data will be done

    at day 1

Study Arms (2)

CSWS patients

The data of CSWS patients will be statistically compared to healthy volunteers

Other: Continuous spikes and waves during slow sleep (CSWS)

healthy volunteers

The data of CSWS patients will be statistically compared to healthy volunteers

Other: Continuous spikes and waves during slow sleep (CSWS)

Interventions

CSWS patientshealthy volunteers

Eligibility Criteria

Age5 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

patients, diagnosis of CSWS according to the current diagnostic criteria (ILAE 2001)

You may qualify if:

  • \- for the patients, diagnosis of CSWS according to the current diagnostic criteria (ILAE 2001)
  • minimal age of 5 years old
  • written consent to participate in the study from the subjects who could write and/or from the parents or legal representative

You may not qualify if:

  • rejection of the patient or its legal representative

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Clermont-Ferrand

Clermont-Ferrand, 63003, France

RECRUITING

MeSH Terms

Conditions

EpilepsyNervous System Diseases

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System Diseases

Study Officials

  • Dominique ROSENBERG

    University Hospital, Clermont-Ferrand

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 13, 2017

First Posted

January 30, 2017

Study Start

January 1, 2017

Primary Completion

February 1, 2020

Study Completion

February 1, 2020

Last Updated

January 30, 2017

Record last verified: 2017-01

Locations